GGrantIndex
← Leaderboards

Richard R Drake

University Of Arkansas Med Scis Ltl Rock

Google Scholar ↗PubMed ↗ORCID ↗
$9,503,019
Attributed
$16,236,503
Total exposure
17
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY2005–25
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,236,503 · 17

By mechanism

R01$7,340,429 · 4
U01$3,606,064 · 2
R21$1,947,362 · 4
U54$1,312,724 · 3
P30$1,041,703 · 3
R33$988,221 · 1

Top collaborators

Others in their field

Top investigators on “Tissues”

Research focus

TissuesPolysaccharidesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationImageSamplingProteinsLinkCellsComplexProteomicsMass Spectrum AnalysisSerumBaseGlycosylationMalignant NeoplasmsResourcesBiological MarkersDetectionResearch PersonnelAlzheimer&AposCohortGlycoproteinsTumorMolecular

Grant awards (49)

Deciphering the Glycan Code in Human Alzheimer's Disease Brain$736,681
R01 · FY2025 · AG
Proteomics Core$151,198
P30 · FY2025 · DK · contact PI
Deciphering the Glycan Code in Human Alzheimer's Disease Brain$756,289
R01 · FY2024 · AG
Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids$320,531
R33 · FY2024 · CA · contact PI
Proteomics Core$178,101
P30 · FY2024 · DK · contact PI
Deciphering the Glycan Code in Human Alzheimer's Disease Brain$760,730
R01 · FY2023 · AG
Glycopathology of HCC: identification of the source cells of serum fucosylation$603,318
U01 · FY2023 · CA
Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids$330,654
R33 · FY2023 · CA · contact PI
Proteomics Core$178,101
P30 · FY2023 · DK · contact PI
Deciphering the Glycan Code in Human Alzheimer's Disease Brain$791,294
R01 · FY2022 · AG
Glycopathology of HCC: identification of the source cells of serum fucosylation$603,318
U01 · FY2022 · CA
Tumor immune and glycan biomarkers for progressive prostate cancer$552,871
R01 · FY2022 · CA
Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids$337,036
R33 · FY2022 · CA · contact PI
Proteomics Core$178,101
P30 · FY2022 · DK · contact PI
Deciphering the Glycan Code in Human Alzheimer’s Disease Brain$1
R01 · FY2022 · AG
Tumor immune and glycan biomarkers for progressive prostate cancer$561,790
R01 · FY2021 · CA
Glycopathology of HCC: identification of the source cells of serum fucosylation$413,676
U01 · FY2021 · CA
Simplified Glycan Profiling Workflows of Captured Immune Glycoproteins and Cells$254,212
U01 · FY2021 · CA · contact PI
Proteomics Core$178,101
P30 · FY2021 · DK · contact PI
Glycopathology of HCC: identification of the source cells of serum fucosylation$615,632
U01 · FY2020 · CA
Tumor immune and glycan biomarkers for progressive prostate cancer$529,005
R01 · FY2020 · CA
Simplified Glycan Profiling Workflows of Captured Immune Glycoproteins and Cells$281,657
U01 · FY2020 · CA · contact PI
Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors$189,411
U54 · FY2020 · MD · contact PI
Proteomics Core$178,101
P30 · FY2020 · DK · contact PI
Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors$46,533
U54 · FY2020 · MD · contact PI
Glycopathology of HCC: identification of the source cells of serum fucosylation$552,594
U01 · FY2019 · CA
Tumor immune and glycan biomarkers for progressive prostate cancer$513,134
R01 · FY2019 · CA
Simplified Glycan Profiling Workflows of Captured Immune Glycoproteins and Cells$281,657
U01 · FY2019 · CA · contact PI
Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors$266,196
U54 · FY2019 · MD · contact PI
Tumor immune and glycan biomarkers for progressive prostate cancer$563,176
R01 · FY2018 · CA
Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors$300,888
U54 · FY2018 · MD · contact PI
Detection and Histopathology Localization of O-Glycans and Glycosaminoglycans in Tissues$273,585
R21 · FY2017 · CA · contact PI
Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors$252,630
U54 · FY2017 · MD · contact PI
Detection and Histopathology Localization of O-Glycans and Glycosaminoglycans in Tissues$273,585
R21 · FY2016 · CA · contact PI
Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors$257,066
U54 · FY2016 · MD · contact PI
Direct Tumor Glycan Profiling on Tissue Microarrays$248,170
R21 · FY2016 · CA · contact PI
Direct Tumor Glycan Profiling on Tissue Microarrays$248,170
R21 · FY2015 · CA · contact PI
Glycan Biomarkers of Prostate Cancer in Prostatic Fluids$254,870
R01 · FY2012 · CA · contact PI
Glycan Biomarkers of Prostate Cancer in Prostatic Fluids$236,297
R01 · FY2011 · CA · contact PI
Glycan Biomarkers of Prostate Cancer in Prostatic Fluids$243,605
R01 · FY2010 · CA · contact PI
Proximal Prostate Fluids for Protein and miRNA Biomarkers$157,850
R21 · FY2010 · CA · contact PI
Glycan Biomarkers of Prostate Cancer in Prostatic Fluids$254,480
R01 · FY2009 · CA · contact PI
Proximal Prostate Fluids for Protein and miRNA Biomarkers$189,420
R21 · FY2009 · CA · contact PI
Proteomic Profiling for Influenza Vaccination/Infection$274,982
R21 · FY2006 · AI · contact PI
Proteomic Profiling for Influenza Vaccination/Infection$281,600
R21 · FY2005 · AI
ENGINEERED THYMIDINE KINASES FOR CANCER GENE THERAPY$191,918
R01 · FY2002 · CA
ENGINEERED THYMIDINE KINASES FOR CANCER GENE THERAPY$105,007
R01 · FY2001 · CA
ENGINEERED THYMIDINE KINASES FOR CANCER GENE THERAPY$96,654
R01 · FY2001 · CA
ENGINEERED THYMIDINE KINASES FOR CANCER GENE THERAPY$192,627
R01 · FY2000 · CA